Kenya Oncology Clinical Trials Market Report 2022 to 2030

Kenya Oncology Clinical Trials Market Analysis

$ 3999

Kenya's oncology clinical trials market is projected to grow from $8.86 Mn in 2022 to $14.8 Mn by 2030, registering a CAGR of 6.6% during the forecast period of 2022-30. The market will be driven by the country's high cancer burden and increased interest in conducting clinical trials in the nation by global pharmaceutical corporations. The market is segmented by phase, study design, and indication. Some of the major players include Pfizer Inc., Roche Holding AG, and Novartis International AG.

ID: IN10KECT006 CATEGORY: Clinical Trials GEOGRAPHY: Kenya AUTHOR: Vidhi Upadhyay

Buy Now

Kenya Oncology Clinical Trials Market Executive Summary

Kenya's oncology clinical trials market is projected to grow from $8.86 Mn in 2022 to $14.8 Mn by 2030, registering a CAGR of 6.6% during the forecast period of 2022-30. Kenya was the third biggest economy in Sub-Saharan Africa as of 2020, after only Nigeria and South Africa. In Kenya, noncommunicable diseases (NCDs) account for 37% of DALYs. In Kenya, the likelihood of acquiring cancer before the age of 75 years (%) is 18% for women and 14.3% for men, while the risk of dying from cancer before the same age is 12.7% for women and 10.3% for men. The five most common cancers in Kenya for both sexes are breast, cervical, prostate, oesophageal, and colorectal.

The environment for oncology clinical trials in Kenya is still developing, although there has been a surge in interest in cancer research and therapy in recent years. Cancer is a major problem in the nation. Several hospitals and research centers in Kenya such as Aga Khan University Hospital, Kenyatta National Hospital, Kenya Medical Research Institute & University of Nairobi are involved in oncology clinical trials. While the oncology clinical trials scenario in Kenya has both opportunities and challenges, the country's increased interest in cancer research and therapy, as well as its dedication to establishing its research infrastructure, implies that it has the possibility of becoming a significant player in the global oncology research landscape.

kenya oncology clinical trials market analysis

Market Dynamics

Market Growth Drivers

Many reasons are driving the expansion of oncology clinical trials in Kenya. One of the primary factors is the country's high cancer burden, which has led to an increase in interest in cancer research and treatment among researchers, doctors, and legislators. This has resulted in high demand for novel treatments as well as a better knowledge of the genetic and molecular pathways behind various forms of cancer in the Kenyan population. Another driver of oncology clinical trials in Kenya is the increased interest in conducting clinical trials in the nation by global pharmaceutical corporations. As Kenya's healthcare system develops and improves, pharmaceutical firms are more interested in establishing a presence in the nation and undertaking clinical studies focusing on cancer treatment and prevention.

Market Restraints

There are also various barriers to the expansion of oncology clinical trials in Kenya. Scarcity of skilled professionals, such as clinical trial coordinators, data managers, and regulatory specialists. This may make conducting clinical studies that fulfill international standards and regulatory criteria challenging. Another constraint is the scarcity of financing for clinical trials, especially for smaller or independent research institutes. This may make conducting high-quality clinical studies that match international requirements and capture the attention of multinational pharmaceutical corporations challenging.

Competitive Landscape

Key Players

Pfizer Inc.
Roche Holding AG
Novartis International AG
AstraZeneca plc
Merck & Co., Inc.
Eli Lilly and Company
Sanofi S.A.
Bristol Myers Squibb Company

Notable Insights

February 2023, The Aga Khan University Hospital, Nairobi (AKUH, N) has initiated the first cancer drug clinical trial in Africa to test the efficacy of a novel medicine that inhibits the function of a gene mutation that causes cancer in affected patients. AKUH, N is Africa's sole location chosen for the trial of this novel medicine.
February 2023, The Aga Khan University Hospital in Nairobi, Kenya, has started a clinical study in solid tumors using Roche's experimental KRAS G12C inhibitor GDC-6036.
November 2022, The University of Nairobi, via the University of Nairobi Institute of Tropical and Infectious Diseases (UNITID), and Roche signed an MoU to collaborate. While commenting on this relationship, Prof. Julius Oyugi, Director of UNITID, revealed that Roche has recognized UNITID as a viable partner to cooperate with on clinical studies on cancer drugs beginning in January 2023.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Clinical Trials Regulation in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation

6. Methodology and Scope

Oncology Clinical Trials Market Segmentation

By Phase (Revenue, USD Billion):

Phase I
Phase II
Phase III
Phase IV

By Study Design Outlook (Revenue, USD Billion):

Epilepsy
Parkinson's Disease (PD)
Huntington's Disease
Stroke
Traumatic Brain Injury (TBI)
Amyotrophic Lateral Sclerosis (ALS)
Muscle regeneration
Others

By Indication Outlook (Revenue, USD Billion):

Interventional
Observational
Expanded Access

Insights10 will provide you with the reports within 10 key parameters which are:

Market Overview
Market Growth Drivers & Restraints
Epidemiology of Disease Type
Market Segmentation
Market Share
Competitive Landscape
Key Company Profiles
Healthcare Policies & Regulatory Framework
Reimbursement Scenario
Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

Establishing market drivers and trends
Analyzing the regulatory landscape to understand future growth
Market Segment based analysis to obtain revenue/volume
Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.